Author

Kazuki Sakamoto

Taiho Pharmaceutical Co., Ltd. - Cited by 1,185 - Oncology

Biography

Dr. Kazuki Sakamoto currently working in Sakamoto Hospital, Kagawa, Japan. Kazuki Sakamoto published many research and review articles. Kazuki Sakamoto received many awards and medals for his health care service for the patients.
Title
Cited by
Year
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations
H Yabuuchi, I Tamai, JI Nezu, K Sakamoto, A Oku, M Shimane, Y Sai, ...Journal of Pharmacology and Experimental Therapeutics 289 (2), 768-773, 1999199
389
1999
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models
N Tanaka, K Sakamoto, H Okabe, A Fujioka, K Yamamura, F Nakagawa, ...Oncology reports 32 (6), 2319-2326, 2014201
129
2014
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
H Tsukihara, F Nakagawa, K Sakamoto, K Ishida, N Tanaka, H Okabe, ...Oncology reports 33 (5), 2135-2142, 2015201
89
2015
A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3′-ethynyl nucleosides
D Murata, Y Endo, T Obata, K Sakamoto, Y Syouji, M Kadohira, ...Drug metabolism and disposition 32 (10), 1178-1182, 2004200
63
2004
Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo
M Fukushima, K Sakamoto, M Sakata, F Nakagawa, H Saito, Y SakataOncology reports 24 (5), 1307-1313, 2010201
56
2010
Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides
Y Endo, T Obata, D Murata, M Ito, K Sakamoto, M Fukushima, Y Yamasaki, ...Cancer science 98 (10), 1633-1637, 2007200
45
2007
Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer
Y Yonemura, Y Endo, T Takino, K Sakamoto, E Bandou, K Kinoshita, ...Clinical & experimental metastasis 18, 321-327, 2000200
38
2000
Folylpolyglutamate synthase and γ-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity
E Sakamoto, S Tsukioka, S Oie, T Kobunai, H Tsujimoto, K Sakamoto, ...Biochemical and biophysical research communications 365 (4), 801-807, 2008200
38
2008
Influence of cytidine deaminase on antitumor activity of 2′-deoxycytidine analogs in vitro and in vivo
T Yoshida, Y Endo, T Obata, Y Kosugi, K Sakamoto, T SasakiDrug metabolism and disposition 38 (10), 1814-1819, 2010201
27
2010
Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice
M Nukatsuka, H Saito, F Nakagawa, H Tsujimoto, K Sakamoto, ...Experimental and therapeutic medicine 3 (5), 755-762, 2012201
25
2012
Possible antitumor activity of 1‐(3‐C‐ethynyl‐β‐d‐ribo‐pentofuranosyl)cytosine (ECyd, TAS‐106) against an established gemcitabine (dFdCyd)‐resistant human …
H Kazuno, K Sakamoto, A Fujioka, M Fukushima, A Matsuda, T SasakiCancer science 96 (5), 295-302, 2005200
24
2005
Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo
M Nukatsuka, H Saito, K Sakamoto, F Nakagawa, J Uchida, T Kobunai, ...Anticancer research 32 (7), 2807-2812, 2012201
21
2012
Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysis
S Kamoshida, K Watanabe, M Suzuki, Y Mizutani, K Sakamoto, ...Biomedical Research 27 (6), 275-281, 060
20
2006
Effect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthase
H TSUjIMOTO, S Tsukioka, S Ono, E Sakamoto, K Sakamoto, K Tsuta, ...Oncology Letters 1 (6), 973-980, 101
20
2010
Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase
M Fukushima, K Sakamoto, H Ohshimo, F Nakagawa, T TaguchiOncology reports 24 (4), 835-842, 2010201
19
2010
Expression of chemoresistance-related proteins in α-fetoprotein-producing adenocarcinoma of the digestive organs
S Kamoshida, M Suzuki, Y Sakurai, M Ochiai, F Kimura, S Kuwao, ...Oncology reports (4), 721-727, 2006200
16
2006
Orotate phosphoribosyltransferase levels measured by a newly established enzyme‐linked immunosorbent assay in gastric carcinoma
Y Sakurai, K Sakamoto, Y Sugimoto, I Yoshida, T Masui, S Tonomura, ...Cancer science 97 (6), 492-498, 2006200
14
2006
Selective oxidation of methane to formaldehyde over a silica-supported cobalt single-atom catalyst
J Ohyama, D Abe, A Hirayama, H Iwai, Y Tsuchimura, K Sakamoto, ...The Journal of Physical Chemistry C 126 (4), 1785-1792, 2022202
11
2022
Heat-assisted stretching of paraffin sections on hot plate weakens immunoreactivity of orotate phosphoribosyltransferase
S Kamoshida, N Sakamoto, H Matsuoka, Y Sakurai, K Sakamoto, ...Acta Histochemica et Cytochemica 38 (1), 69-74, 2005200
11
2005
Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells
K Sakamoto, Y Sugimoto, K Miyadera, T Oka, M FukushimaInternational journal of molecular medicine 16 (2), 245-24, 2005200
9
2005

Referred From: https://scholar.google.com/citations?hl=en&user=nFjPrjoAAAAJ

Cited by
Citations 1185
h-index 17
i10-index 21
Recommended Journals
Open Access Journals